David Sarwer

2.4K posts

David Sarwer banner
David Sarwer

David Sarwer

@davidbsarwer

Senior Associate Dean for Research and Strategic Initiatives, Director of Center for Obesity Research and Education, College of Public Health, Temple University

Blue Bell, PA Beigetreten Nisan 2016
944 Folgt913 Follower
David Sarwer
David Sarwer@davidbsarwer·
Pleased to have had the opportunity to talk about the potential of the oral GLP-1s to increase access to obesity treatment. @TempleCPH @TempleResearch @TempleHealth @TempleSBS @thephillyvoice @ObesityAction @WorldObesity
Temple Research & Innovation@TempleResearch

New GLP-1 pills could expand access but cost and inconsistent insurance coverage pose hurdles. As @davidbsarwer @TempleCPH notes: “We need to figure out the best ways we can make these medications affordable… in the short & long term.” @thephillyvoice phillyvoice.com/weight-loss-pi…

English
0
2
3
327
David Sarwer
David Sarwer@davidbsarwer·
More great and important work by @HamletGasoyan and colleagues on real world use of the GLP-1s to treat #obesity. Studies like this are critical to help us guide policy as well as critical adjunctive strategies to promote enduring obesity management.
Hamlet Gasoyan@HamletGasoyan

In a new study of 7938 patients who initiated semaglutide or tirzepatide for obesity or diabetes and discontinued the medication within 3–12 months, we examined what additional obesity treatment patients pursue and weight changes post-discontinuation. doi.org/10.1111/dom.70…

English
0
1
1
235
David Sarwer retweetet
Hamlet Gasoyan
Hamlet Gasoyan@HamletGasoyan·
In a new study of 7938 patients who initiated semaglutide or tirzepatide for obesity or diabetes and discontinued the medication within 3–12 months, we examined what additional obesity treatment patients pursue and weight changes post-discontinuation. doi.org/10.1111/dom.70…
English
2
7
22
6.8K
David Sarwer
David Sarwer@davidbsarwer·
Thrilled to have had an opportunity to comment on all of the ads for obesity management medications during the Super Bowl. Public awareness about evidence based treatments is critically important. ⁦@TempleCPH⁩ ⁦@TempleResearch⁩ ⁦ yahoo.com/lifestyle/arti…
English
0
1
2
51
David Sarwer
David Sarwer@davidbsarwer·
Great article on my colleague and collaborator @HamletGasoyan on how he used his experience and training @TempleCPH to become a rapidly rising star at @ClevelandClinic doing impactful work on use of #obesity treatments. @WorldObesity @TempleResearch @ObesitySociety
Temple Public Health@TempleCPH

🔍 From data to decisions: Discover how CPH alum Hamlet Gasoyan, DS, PhD, MPH, is turning real-world obesity research into insights that inform health policy and improve treatment access. 👉 buff.ly/mLkg27C

English
0
4
5
423
Jimmy Kempski
Jimmy Kempski@JimmyKempski·
Sirianni/Patullo are in full-on "Call nothing even remotely risky and Vic please get like 3 or 4 more stops cool thanks" mode.
English
174
591
5.9K
338.1K
David Sarwer
David Sarwer@davidbsarwer·
Great to see this video describing the psychological considerations of metabolic and bariatric surgery to treat #obesity reposted today. Thanks @IfsoSecretariat @WorldObesity @ObesitySociety @TempleCPH @TempleUniv @ObesityAction @WileyHealth
IFSO@IfsoSecretariat

@davidbsarwer highlights an important reality: many patients seeking MBS experience psychosocial distress. These factors influence treatment adherence and wellbeing. Most patients experience major improvements after surgery, but proper psychological preparation is essential.

English
0
1
3
63
David Sarwer
David Sarwer@davidbsarwer·
Thrilled to have my recent article in @ConversationUS featured along side those of @marionnestle and @astokespop in this great piece by @ConscienHealth on the importance of obesity prevention and treatment. @TempleCPH @TempleResearch @TempleUniv @WorldObesity @ObesitySociety
Ted Kyle@ConscienHealth

We agree when @marionnestle, @astokespop, and @davidbsarwer say don't neglect #ObesityPrevention. But we are suspecting that market dynamics are doing more to bend the curve than many health advocates. It's time to catch up with reality. conscienhealth.org/2025/12/will-h…

English
0
4
3
1.2K
Andrew Brandt
Andrew Brandt@AndrewBrandt·
I now live in Philly area, but lived in Green Bay for a decade. There’s Northeast cold, and then there’s upper Midwest cold. The latter hits different. A whole different level of cold 🥶.
English
29
11
421
209.4K
David Haugh
David Haugh@DavidHaugh·
This better work. I get it, but … Sitting your hottest hitter of late in a key playoff game — even for 1 AB, even if it plays to handedness, even if it’s for a guy with postseason experience — one game after he led off game with a HR, seems like over-managing to me. Ugh.
Chicago Cubs@Cubs

Game 2.

English
68
19
310
74.6K
David Sarwer retweetet
Hamlet Gasoyan
Hamlet Gasoyan@HamletGasoyan·
🚨 Treatment discontinuation is common in patients receiving semaglutide or tirzepatide for obesity. This is the first US study to quantify the specific reasons for discontinuation in clinical practice. doi.org/10.1002/oby.70…
Hamlet Gasoyan tweet media
English
2
3
4
540
David Sarwer retweetet
Bariatric News
Bariatric News@BariatricNews·
Journal Watch: Our regular round-up includes laparoscopic reversal of gastric bypass, surgery vs GLP-1ras, GLP-1s in a plastic surgery setting, magnetic sphincter augmentation & post-LSG GERD, obesity severity and cancer screening, and more shorturl.at/nogVL
Bariatric News tweet media
English
0
1
1
90
David Sarwer
David Sarwer@davidbsarwer·
Appreciate @BariatricNews picking up our recent article on utilization and potential misuse of GLP-1’s in the absence of training and experience in comprehensive obesity treatment. @TempleCPH @TempleResearch @TempleSBS @ConscienHealth @ObesityAction @prsjournal @WorldObesity
Bariatric News@BariatricNews

Researchers @TempleCPH are warning how some plastic surgeons (PS) are promoting GLP-1s & using them to treat patients & are treating obesity as a cosmetic issue rather than a chronic disease & have made a series of recommendations to PS prescribing GLP-1s shorturl.at/6IqC9

English
0
1
3
165

Entdecken

@TempleCPH @TempleResearch @TempleHealth @TempleSBS @thephillyvoice @ObesityAction @WorldObesity @HamletGasoyan